This report studies the Antibody Production Market for the forecast period of 2016 to 2021. This market is expected to reach USD 13.28 Billion by 2021 from USD 7.45 Billion in 2016, at a CAGR of 12.3%.

A number of factors such as the improved approval rate for therapeutic antibodies by regulatory authorities, patent expiry of blockbuster monoclonal antibodies, increasing adoption of targeted immunotherapy, and increased R&D expenditure of pharmaceutical and biotechnology companies are key drivers for the growth of the antibody production market. Moreover, the increasing risk of infectious diseases and rising demand for protein therapeutics are expected to drive market growth during the forecast period.

In this report, the antibody production market is segmented on the basis of process, end user, and region. Based on process, the antibody production market is categorized into products for upstream processing, downstream processing, and filtration. The downstream processing segment is expected to account for the largest share of the antibody production market in 2016. This segment is also projected to register the highest CAGR during the forecast period.

                               Get the Sample pages for More Details@ http://bit.ly/2Ts3aNe

On the basis of end user, the antibody production market is segmented into pharmaceutical and biotechnology companies, research institutes, and diagnostic laboratories. The pharmaceutical and biotechnology companies segment is expected to account for the largest share of the market in 2016, and is projected to register the highest CAGR during the forecast period.

Geographically, the global antibody production market is divided into North America, Europe, Asia-Pacific, and the Rest of the World (Latin America, Middle East, and Africa). North America is expected to account for the largest share of the antibody production market in 2016, followed by Europe. The Asia-Pacific region offers significant growth opportunities for companies offering antibody production products, and is projected to grow at the highest CAGR during the forecast period.

The prominent players in the antibody production market include GE Healthcare (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Sartorius AG (Germany), Merck KGaA (Germany), Pall Corporation (U.S.), Sigma-Aldrich Corporation (Germany), Eppendorf AG (Germany), Cellab GmbH (Germany), INTEGRA Biosciences AG (Switzerland), and FiberCell Systems Inc. (U.S.).

Target Audience:

# Equipment and consumable manufacturing companies
# Equipment and consumable suppliers and distributors
# Research institutes
# Venture capitalists
# Biotechnology and pharmaceutical companies
# Diagnostic laboratories

You Can Also Talk to Our Research Experts for More Detailed Information@ http://bit.ly/2Ttvhvz

Scope of the Report

The research report categorizes the global market into the following segments and subsegments:

Antibody Production Market, by Process

• Upstream Processing
  • Bioreactors
    • Large-scale bioreactors
    • Single-use bioreactors
  • Consumables
    • Media
    • Buffers and reagents
• Downstream Processing
  • Chromatography Systems
  • Chromatography Resins
• Filtration
  • Filtration Systems
  • Filtration Consumables and Accessories

Antibody Production Market, by End User

• Pharmaceutical and Biotechnology Companies
• Diagnostic Laboratories
• Research Institutes

Antibody Production Market, by Region

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • U.K.
  • France
  • Italy
  • Rest of Europe (RoE)
• Asia-Pacific
  • Japan
  • China
  • India
  • Rest of Asia-Pacific
• RoW
  • Latin America
  • Middle East and Africa

Read More:
https://www.marketsandmarkets.com/Market-Reports/antibody-production-market-181543091.html